We found a family with a high activity for hydrolyzing L-alanylp-naphthylamide in their serum. This enzyme was confirmed to be aminopeptidase (microsomal) (EC 3.4.11.2) To our knowledge, there is no report of a family with a high serum AP activity in the English literature.
catalyzes the splitting of such amino acid arylamides as ialanyl-f3-naphthylamide. Widely distributed in the tissues and body fluids (1), AP is generally determined in serum by using synthetic amino acid naphthylamide or p-nitroanilide substrates. However, synthetic substrates may be hydrolyzed by various serum peptidases.
To our knowledge, there is no report of a family with a high serum AP activity in the English literature.
Here we report such a family, and also the characteristics of AP concentrated from the serum of the propositus.
Case Report
A 15-year-old boy was admitted to a hospital for psychiatric diseases, because of abnormal behavior. He was diagnosed as having a psychogenic reaction. On admission, physical and biochemical examinations revealed no abnormalities except for very high AP activity in the serum. Because none of the known causes for increased activity of serum AP were detected, we proceeded to examine the enzyme activity in serum from his parents and paternal grandmother, all of whom were healthy. We found a high AP activity in his father's serum, whereas his mother and grandmother had normal values. Figure 1 shows the pedigree of his family with high serum AP activity, insofar as it is known.
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Materials and Methods

Materials
Apparatus:
We used a 110-mL LKB 8100 Ampholine column (LKB-Produkter, Bromma, Sweden) for preparative isoelectric focusing.
Reagents: 
Samples and antiserum:
Blood samples from the propositus, his parents, and his grandmother were collected without the use of anticoagulant. Outdated blood-bank plasma was used as the source of normal AP. Purified AP from human kidney used in this study was prepared as described previously (2) . Antiserum to human kidney AP, raised in rabbits (2), was used in this study.
Enzyme assay and unit:
The activity of AP was determined with L-alanyl-/3-naphthylamlde (0.5 mmoilL) as substrate in phosphate buffer (0.1 mol/L, pH 7.0) at 37 #{176}C (2).
One unit (U) of the activity was defined as that amount of the enzyme necessary to hydrolyze 1 mol of substrate per minute.
Procedures
Electrophoresis on polyacrylamide gel. Electrophoresis was carried out on polyacrylamide disc gel (65 g of polyacrylamide and 2 g of N,N'-methylenebisacrylamide per liter of Tris HC1 buffer, 375 mmol/L, pH 8.6) as described previously (2) .AP activity on polyacrylamide gel was located by using L-leucyl-4-methoxy-/3-naphthylamide as substrate and staining with Fast Blue B salt (3).
Preparative isoelectric focusing.
This was performed according to the method of Vesterberg (4), the duration of focusing being about 48 h. We measured enzyme activity in the 2.6-mL fractions collected. pH was measured at 4#{176}C. 3), we applied the dialyzed sample (total protein, 1430 mg; total activity, 38.64 U) to a 5 x 25 cm column of DE52 equilibrated with phosphate buffer (10 mmollL, pH 7.3). After washing the column with the starting buffer, we developed the column with a linear gradient of NaCl, using 800 mL of starting buffer and 800 mL of 0.3 mol/L NaCl in starting buffer. The fractions containing AP activity were collected, concentrated by ultrafiltration as described above, then dialyzed against Tris HC1 buffer (20 mmol/L, pH 7.0) containing 0.5 mol of NaCl and 1 mmol each of CaCl2, MnCl2, and MgCl2 per liter. The dialyzed sample (total protein, 1087 mg; total activity, 27.82 U) was applied to a 2.6 x 20 cm column of concanavalin ASepharose, previously equilibrated with the above dialyzing buffer. After washing the column with the starting buffer, we washed the column with a 10 mmolIL solution of glucose in the same buffer. Then the enzyme was eluted with a 100 mmolIL solution of mannose in the starting buffer. The active fractions were pooled, concentrated by ultrafiltration, and dialyzed against phosphate buffer (1 mmol/L, pH 7.0). The dialyzed sample (total protein, 339.4 mg; total activity, 20.3 U) was applied to a 2.6 x 15 cm column of hydroxyapatite, previously equilibrated with the above dialyzing buffer and washed with the starting buffer. The enzyme adsorbed on the column was eluted with a linear gradient of pH 7.0 phosphate buffer, increasing in molarity from 1 mmolfL (300 mL) to 200 mmol/L (300 mL). The active fractions were pooled and concentrated to 3 mL. The entire concentrated sample (total protein, 10.4 mg; total activity, 13.1 U) was applied to a 2.6 x 90 cm column of Sephadex G-200 equilibrated with phosphate buffer (10 mmolfL, pH 7.3) containing 1 g of NaN3 per liter. A single peak of activity peak of activity was obtained. The specific activity was 9.45 kU/g of protein, about a 5000-fold purification. The analytical recovery was 16%.
Determination
Immunological Studies
Immunoinhibition study. Partly purified AP from the propositus' serum (P-AP) (activity, 3 mU) and highly purified AP from the outdated blood-bank plasma (N-AP) (activity, 3 mU) were incubated with 0.1-10 ML of antiserum to human kidney AP in phosphate buffer (0.1 mol/L, pH 7.0) for 30 mm at 37 #{176}C, and the remaining enzyme activities were measured.
Double immunodiffusion.
For the double immunodiffusion studies we used agar gel, 12 g/L of barbital buffer (50 mmol/L, pH 8. 
Polyacrylamide Disc Gel Electrophoresis
The electrophoretic mobilities of serum AP from the propositus and his father differed from those of his mother and a normal male subject. R values of the enzymes from the propositus and his father were similar (0.58); those of his mother and a normal male subject were 0.51. After neuraminidase treatment, the electrophoretic mobilities of the enzymes from the propositus (Rf, 0.43) and a normal subject (Rf, 0.37) were decreased by a similar amount ( Figure  2 ). Neuraminidase treatment had no effect on AP activity from either source. Symbols as in Fig. 1 Characteristics of the Enzyme Apparent molecular mass. The apparent molecular masses of partly purified AP from the serum of the propositus (P-AP) and highly purified AP from outdated blood-bank plasma (N-AP), as determined by gel ifitration on the Sephadex G-200 column, were both 240 000 Da.
Isoelectric point. Isoelectric points of P-AP and N-AP were pH 3.4 and pH 3.8, respectively.
After treatment with neuraminidase, these respective isoelectric points were pH 4.5 and 4.8.
Heat stability. To test heat stability, we preincubated both APs at 65 #{176}C for 5 to 30 mm in phosphate buffer (0.b mol/L, pH 7.0) and measured the remaining activities. As shown in Figure 3 , P-AP was consistently more heat-labile than N-AP.
Km value. Km values of P-AP and N-AP in phosphate buffer (0.1 mol/L, pH 7.0) were determined from a Lineweaver-Burk plot. Both had the same Km value, 87
Mmol/L. Immunological properties.
P-AP and N-AP were neutralized very similarly by antiserum to human kidney AP (Figure 4) . Double immunodiffusion against this antiserum 
Discussion
Any relationship between psychogenic reaction and high serum AP activity is doubtful, because the propositus' father, who had a high serum AP activity, was mentally normal.
Moreover, we tested more than 100 patients who had psychogenic reaction, and all had normal serum AP activity.
AP activity is high in the brush border membrane of intestinal mucosa and in renal proximal tubules (2, 6, 7) , as well as in microvilli of bile ducts and canaliculi (8) . Although liver is said to be the principal source of serum AP
(1), this has not been definitively established. Serum AP activity is considerably increased in diseases of the liver and pancreas and in malignant diseases (1, 9, 10) . The propositus and his father had normal liver function and no signs or symptoms of malignant diseases. The clearance rate for serum AP is unknown.
Its molecular mass exceeds 200 000 Da. Under normal conditions, serum AP is not detectable in urine (11) . We are unable to conclude whether the production and (or) release of the enzyme is increased or the degradation of the enzyme is decreased. P-AP resembled N-AP in molecular size and kinetic and immunological properties, but differed from N-AP with respect to electrophoretic mobility, isoelectric point, and heat stability.
After treatment of the two enzymes with neuraminidase, their electrophoretic mobilities and isoelectric points still did not coincide.
In 1981, a family with a high serum arylamidase activity was reported in the Japanese literature by Kumada et al. (12) . They measured the enzyme activity and Km value with four synthetic substrates. Detailed properties of the enzyme that was increased in serum were not described, but it seems to be AP. The pedigree of that family is shown in Figure 6 .
